TransMedics Group, Inc.

86
Strong Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US89377M1099
USD
124.70
1.22 (0.99%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
TransMedics Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
107.00
35.00
-26.00
-36.00
-44.00
-28.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
18.00
-45.00
-44.00
-26.00
3.00
-5.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
192.00
48.00
-13.00
-45.00
-28.00
-30.00
Cash Flow from Investing Activities
-59.00
-129.00
-193.00
54.00
29.00
-41.00
Cash Flow from Financing Activities
16.00
22.00
400.00
167.00
1.00
75.00
Net Cash Inflow / Outflow
151.00
-58.00
193.00
175.00
0.00
4.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1.00
0.00
0.00
-1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of TransMedics Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
107.522
-82.263
189.00
230.71%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
18.376
-16.327
34.00
212.55%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
192.84
-34.23
226.00
663.37%
Cash Flow from Investing Activities
-59.251
46.339
-105.00
-227.86%
Cash Flow from Financing Activities
16.857
-4.555
20.00
470.08%
Net Cash Inflow / Outflow
151.716
8.991
143.00
1587.42%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1.27
1.437
0.00
-11.62%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 295.14% vs 474.60% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
192.84
48.80
295.14%